ID: ALA5268359

Max Phase: Preclinical

Molecular Formula: C18H15N3O2

Molecular Weight: 305.34

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-n2nc3c4ccc(C)cc4[nH]cc-3c2=O)cc1

Standard InChI:  InChI=1S/C18H15N3O2/c1-11-3-8-14-16(9-11)19-10-15-17(14)20-21(18(15)22)12-4-6-13(23-2)7-5-12/h3-10,19H,1-2H3

Standard InChI Key:  UYZOHRCFAMTBIC-UHFFFAOYSA-N

Associated Targets(non-human)

Gamma-aminobutyric acid receptor subunit alpha-6/beta-3/gamma-2 184 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 305.34Molecular Weight (Monoisotopic): 305.1164AlogP: 3.14#Rotatable Bonds: 2
Polar Surface Area: 59.91Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.93CX Basic pKa: 3.13CX LogP: 2.77CX LogD: 2.77
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.62Np Likeness Score: -1.12

References

1. Simeone X, Iorio MT, Siebert DCB, Rehman S, Schnürch M, Mihovilovic MD, Ernst M..  (2019)  Defined concatenated α6α1β3γ2 GABAA receptor constructs reveal dual action of pyrazoloquinolinone allosteric modulators.,  27  (14): [PMID:31186146] [10.1016/j.bmc.2019.06.006]

Source